Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin.

At pretretment, oral α-glucosidase inhibitors (α-GI) were more frequently administered to patients in the Dula group, however, the difference did not reach statistical significance.

also in 111,027 other papers